Core Viewpoint - The article discusses the concept of "buy-and-forget" dividend stocks, emphasizing that while this strategy is not without challenges, it is feasible for long-term investors. It highlights the importance of selecting stocks from the Dividend Kings list, which includes companies with a long history of increasing dividends [2][3]. Group 1: Investment Strategy - The "buy-and-forget" approach involves holding onto core dividend stocks indefinitely, regardless of market fluctuations [2]. - Dividend Kings are defined as companies that have consistently paid and increased dividends for over 50 years, making them suitable for long-term investment [2]. Group 2: Stock Selection Criteria - The selection process utilized filters such as: - Investing Ideas: Dividend Kings - Current Analyst Rating: 4 to 5, indicating positive consensus from analysts [3]. - Number of Analysts: 20 or more for reliable consensus [3]. - Market Cap: Large to Mega for safety [3]. - 60-Month Beta: 0 to 1 for stability [3]. - 5-YR Percent Change: 20% and above for capital appreciation potential [3]. Group 3: AbbVie Inc (ABBV) - AbbVie focuses on developing drugs for cancer and immune system disorders, with a stock price around $227 and a 112% gain over the past 5 years [6]. - The company has a 60-month beta of 0.50, indicating relative stability [6]. - AbbVie pays a forward dividend of $6.56, with a quarterly payout of $1.64 per share, resulting in a 2.9% forward yield and a dividend payout ratio of 68.08% [7]. - Recent financials show an annual revenue increase of 3.7% to $56.33 billion, while net income declined by 12% to $4.27 billion, attributed to rising R&D expenses [7].
3 Highest-Yielding Dividend Kings To Buy, Hold, and Forget